Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MF59 is a squalene-based oil-in-water emulsion adjuvant that enhances immunogenicity and efficacy in vaccines. It activates the innate immune system by inducing local production of chemokines and proinflammatory cytokines, recruiting immune cells to the injection site, promoting dendritic cell maturation, and enhancing antigen uptake and presentation. This leads to robust adaptive immune responses, including increased antibody production and T cell activation. MF59 does not target a single receptor but rather activates multiple coordinated mechanisms within the innate immune system.
Induction of local chemokines/cytokines leading to recruitment and activation of innate immune cells (monocytes, granulocytes, dendritic cells), enhanced antigen uptake/presentation, and subsequent adaptive immune response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate Immune System Activation via Squalene-Based Oil-in-Water Emulsion Adjuvant (None).